## APTV: Aptiv PLC - XLY: Consumer Cyclical

### Executive Summary

No thesis match: MRS_20 -2.7% below STRENGTH zone (4.0-10.0%); PEG 1.07 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($73.02)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### News

- **Articles:** 7
- **Sentiment:** Bullish (Bullish: 3, Bearish: 0)

**1. Aptiv PLC $APTV Shares Sold by Neuberger Berman Group LLC**
- Source: MarketBeat | 20251130T122209 | Somewhat-Bullish | Relevance: 100%
- Neuberger Berman Group LLC reduced its stake in Aptiv PLC by 20.7% in Q2 2025, selling 76,543 shares while still holding a significant position. Aptiv reported strong Q2 earnings and revenue, surpassing analyst expectations, and issued positive FY2025 guidance. The article also details other institutional investor activity, stock performance metrics, recent analyst ratings, and an insider stock sale by CAO Allan J. Brazier.

**2. Inceptionr LLC Trims Stock Holdings in Aptiv PLC $APTV**
- Source: MarketBeat | 20251130T111033 | Somewhat-Bullish | Relevance: 98%
- Inceptionr LLC significantly reduced its stake in Aptiv PLC by 46% during Q2 2025, selling 4,284 shares and ending the quarter with 5,022 shares valued at approximately $343,000. Meanwhile, Aptiv exceeded quarterly expectations with strong EPS and revenue results, setting optimistic FY2025 guidance. Corporate insiders also engaged in stock sales, with CAO Allan J. Brazier selling 1,000 shares.

**3. Russell Investments Group Ltd. Lowers Stock Holdings in Aptiv PLC $APTV**
- Source: MarketBeat | 20251201T113435 | Somewhat-Bullish | Relevance: 98%
- Russell Investments Group Ltd. reduced its stake in Aptiv PLC by 30.9% in Q2, selling 189,398 shares, bringing its total holdings to 423,010 shares valued at approximately $29.05 million. Despite this, Aptiv reported strong Q3 results, beating EPS and revenue estimates, and provided upbeat FY2025 guidance. Analyst sentiment remains largely positive with a "Moderate Buy" rating and a consensus price target of $95.42.

**4. Grantham Mayo Van Otterloo & Co. LLC Sells 68,264 Shares of Aptiv PLC $APTV**
- Source: MarketBeat | 20251201T093522 | Neutral | Relevance: 98%
- Grantham Mayo Van Otterloo & Co. LLC significantly reduced its stake in Aptiv PLC (NYSE:APTV) by selling 68,264 shares, decreasing its holdings by 67.9% in the second quarter. Following the sale, the firm now owns 32,341 shares of Aptiv valued at approximately $2.206 million. The article also details other institutional investor activities, insider trading, and Aptiv's recent financial performance and analyst ratings.

**5. 4,617 Shares in Aptiv PLC $APTV Acquired by Elevation Point Wealth Partners LLC**
- Source: MarketBeat | 20251201T093541 | Bullish | Relevance: 97%
- Elevation Point Wealth Partners LLC acquired a new stake of 4,617 shares in Aptiv PLC, valued at approximately $315,000, as reported in their Q2 Form 13F filing. Other institutional investors like Quadrant Capital Group LLC and Boston Partners also adjusted their holdings, bringing institutional ownership to 94.21%. Aptiv reported strong Q3 earnings, beating analyst estimates, and provided positive FY2025 guidance, maintaining a "Moderate Buy" consensus rating among analysts.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 1, Lowers: 1)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-09 | Wells Fargo | $99 | $100 | -1% |
| 2025-12-08 | Morgan Stanley | $84 | $60 | +40% |
| 2025-11-19 | RBC Capital | $101 | $101 | 0% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-09 | Wells Fargo | main | Overweight |
| 2025-12-08 | Morgan Stanley | up | Equal-Weight |
| 2025-11-19 | RBC Capital | reit | Outperform |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 0 ($0.00M) |
| Sells | 6 ($4.38M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 41.4% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 3 / 7 |

**Top Holders:**
- Vanguard Group Inc: 10.8% (-1.0%)
- Blackrock Inc.: 8.0% (+2.2%)
- Massachusetts Financ: 4.3% (-15.7%)
- State Street Corpora: 4.1% (-1.1%)
- Barrow, Hanley Mewhi: 3.2% (-6.9%)

### Key Risks

1. Insider selling cluster: $4.4M in recent transactions.
2. Near-term weakness: 5.6% below SMA50 despite long-term uptrend.
3. Market regime shift could impact high-beta names disproportionately.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 1.07 suggests fair value with growth premium. Insider selling cluster ($4.4M in 90 days), potential headwind. Institutional flow bullish (3 buying vs 7 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $17.1B |
| Beta | 1.52 |
| 52W Range | $47.19 - $88.80 |
| Short Interest | 2.8% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.07 |
| Forward P/E | 9.2 |
| Current P/E | 10.0 |
| YoY Growth | 8.9% |
| EPS Direction | STABLE |

### Technicals

MRS_20 improving modestly (+0.7% over 5 days). Below STRENGTH zone by 6.7pp (needs >4.0% for momentum thesis). Long-term uptrend intact (above SMA200 at 1.09x) but short-term weakness (below SMA20). RSI neutral at 46.

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | -2.73% (CS: 28) | Weak |
| RSI_14 | 46.2 | Neutral |
| MACD Histogram | 0.20 | Bullish |
| vs SMA20 | 0.989x | Below |
| vs SMA50 | 0.944x | Below |
| vs SMA200 | 1.092x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $77.48
- **Stop Loss:** $73.02 (5.8% risk)
- **Target:** $81.94 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 224
- **Position Value:** $17,355.52
- **Portfolio %:** 17.36%
- **Risk Dollars:** $1,000.00
- **Risk Per Trade:** 1.00%
- **Modifiers:** L1 100% | L2 100% | Combined 1.00x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

*NORMAL regime with moderate improvement trajectory. VIX compression from 20.5 to 16.6 over 5 days signals declining fear, while 47% breadth shows narrow but recovering participation. Fed meeting in 6 days creates near-term uncertainty, but AI sector momentum and improving technical setups support selective positioning.*

### Earnings

**Next:** 2026-02-05 (Est: $1.80)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $1.83 | $2.17 | +18.8% |
| 2025Q2 | $1.83 | $2.12 | +15.8% |
| 2025Q1 | $1.53 | $1.69 | +10.1% |
| 2024Q4 | $1.65 | $1.75 | +6.2% |

---
*RULE-based L3 | 2026-01-06 16:36 | MRS_20*